Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2012-09-06 21:03:46 UTC |
---|
Update Date | 2021-09-14 15:45:33 UTC |
---|
HMDB ID | HMDB0029120 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Valylalanine |
---|
Description | Valylalanine is a dipeptide composed of valine and alanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. |
---|
Structure | CC(C)[C@H](N)C(=O)N[C@@H](C)C(O)=O InChI=1S/C8H16N2O3/c1-4(2)6(9)7(11)10-5(3)8(12)13/h4-6H,9H2,1-3H3,(H,10,11)(H,12,13)/t5-,6-/m0/s1 |
---|
Synonyms | Value | Source |
---|
L-Val-L-ala | ChEBI | VA | ChEBI | Valyl-alanine | ChEBI | L-Valyl-L-alanine | HMDB | N-L-Valyl-L-alanine | HMDB | N-Valylalanine | HMDB | V-a Dipeptide | HMDB | VA dipeptide | HMDB | Val-ala | HMDB | Valine alanine dipeptide | HMDB | Valine-alanine dipeptide | HMDB | Valylalanine | ChEBI |
|
---|
Chemical Formula | C8H16N2O3 |
---|
Average Molecular Weight | 188.227 |
---|
Monoisotopic Molecular Weight | 188.116092383 |
---|
IUPAC Name | (2S)-2-[(2S)-2-amino-3-methylbutanamido]propanoic acid |
---|
Traditional Name | (2S)-2-[(2S)-2-amino-3-methylbutanamido]propanoic acid |
---|
CAS Registry Number | 27493-61-4 |
---|
SMILES | CC(C)[C@H](N)C(=O)N[C@@H](C)C(O)=O |
---|
InChI Identifier | InChI=1S/C8H16N2O3/c1-4(2)6(9)7(11)10-5(3)8(12)13/h4-6H,9H2,1-3H3,(H,10,11)(H,12,13)/t5-,6-/m0/s1 |
---|
InChI Key | HSRXSKHRSXRCFC-WDSKDSINSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Dipeptides |
---|
Alternative Parents | |
---|
Substituents | - Alpha-dipeptide
- Valine or derivatives
- N-acyl-l-alpha-amino acid
- N-acyl-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Alanine or derivatives
- Alpha-amino acid or derivatives
- Fatty acyl
- Fatty amide
- N-acyl-amine
- Amino acid or derivatives
- Carboxamide group
- Amino acid
- Carboxylic acid salt
- Secondary carboxylic acid amide
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Primary amine
- Organic zwitterion
- Organic nitrogen compound
- Primary aliphatic amine
- Organic salt
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Organopnictogen compound
- Amine
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | -2.49 | Extrapolated |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Valylalanine,1TMS,isomer #1 | CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C | 1612.4 | Semi standard non polar | 33892256 | Valylalanine,1TMS,isomer #2 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N[C@@H](C)C(=O)O | 1634.6 | Semi standard non polar | 33892256 | Valylalanine,1TMS,isomer #3 | CC(C)[C@H](N)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C | 1637.1 | Semi standard non polar | 33892256 | Valylalanine,2TMS,isomer #1 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C | 1702.2 | Semi standard non polar | 33892256 | Valylalanine,2TMS,isomer #1 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C | 1667.9 | Standard non polar | 33892256 | Valylalanine,2TMS,isomer #2 | CC(C)[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1621.7 | Semi standard non polar | 33892256 | Valylalanine,2TMS,isomer #2 | CC(C)[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1702.8 | Standard non polar | 33892256 | Valylalanine,2TMS,isomer #3 | CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1802.3 | Semi standard non polar | 33892256 | Valylalanine,2TMS,isomer #3 | CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1692.7 | Standard non polar | 33892256 | Valylalanine,2TMS,isomer #4 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C | 1705.5 | Semi standard non polar | 33892256 | Valylalanine,2TMS,isomer #4 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C | 1680.3 | Standard non polar | 33892256 | Valylalanine,3TMS,isomer #1 | CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1824.4 | Semi standard non polar | 33892256 | Valylalanine,3TMS,isomer #1 | CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1784.6 | Standard non polar | 33892256 | Valylalanine,3TMS,isomer #2 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1710.4 | Semi standard non polar | 33892256 | Valylalanine,3TMS,isomer #2 | CC(C)[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1752.9 | Standard non polar | 33892256 | Valylalanine,3TMS,isomer #3 | CC(C)[C@@H](C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1834.8 | Semi standard non polar | 33892256 | Valylalanine,3TMS,isomer #3 | CC(C)[C@@H](C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1827.3 | Standard non polar | 33892256 | Valylalanine,4TMS,isomer #1 | CC(C)[C@@H](C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1916.8 | Semi standard non polar | 33892256 | Valylalanine,4TMS,isomer #1 | CC(C)[C@@H](C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1903.0 | Standard non polar | 33892256 | Valylalanine,1TBDMS,isomer #1 | CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C | 1857.5 | Semi standard non polar | 33892256 | Valylalanine,1TBDMS,isomer #2 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O | 1875.9 | Semi standard non polar | 33892256 | Valylalanine,1TBDMS,isomer #3 | CC(C)[C@H](N)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C | 1863.8 | Semi standard non polar | 33892256 | Valylalanine,2TBDMS,isomer #1 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C | 2128.8 | Semi standard non polar | 33892256 | Valylalanine,2TBDMS,isomer #1 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C | 2080.8 | Standard non polar | 33892256 | Valylalanine,2TBDMS,isomer #2 | CC(C)[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2072.1 | Semi standard non polar | 33892256 | Valylalanine,2TBDMS,isomer #2 | CC(C)[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2143.3 | Standard non polar | 33892256 | Valylalanine,2TBDMS,isomer #3 | CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2260.8 | Semi standard non polar | 33892256 | Valylalanine,2TBDMS,isomer #3 | CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2092.8 | Standard non polar | 33892256 | Valylalanine,2TBDMS,isomer #4 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C | 2150.0 | Semi standard non polar | 33892256 | Valylalanine,2TBDMS,isomer #4 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C | 2083.6 | Standard non polar | 33892256 | Valylalanine,3TBDMS,isomer #1 | CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2491.1 | Semi standard non polar | 33892256 | Valylalanine,3TBDMS,isomer #1 | CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2361.6 | Standard non polar | 33892256 | Valylalanine,3TBDMS,isomer #2 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2366.2 | Semi standard non polar | 33892256 | Valylalanine,3TBDMS,isomer #2 | CC(C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2337.5 | Standard non polar | 33892256 | Valylalanine,3TBDMS,isomer #3 | CC(C)[C@@H](C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2504.3 | Semi standard non polar | 33892256 | Valylalanine,3TBDMS,isomer #3 | CC(C)[C@@H](C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2403.0 | Standard non polar | 33892256 | Valylalanine,4TBDMS,isomer #1 | CC(C)[C@@H](C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2748.6 | Semi standard non polar | 33892256 | Valylalanine,4TBDMS,isomer #1 | CC(C)[C@@H](C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2632.7 | Standard non polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Valylalanine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylalanine 10V, Negative-QTOF | splash10-000i-8900000000-809bdd0688622d28889d | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylalanine 20V, Negative-QTOF | splash10-000i-9100000000-bdd25007d91e14c08370 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylalanine 40V, Negative-QTOF | splash10-0006-9000000000-f51e4d54854c853b7498 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylalanine 10V, Positive-QTOF | splash10-00dr-9500000000-3240d8b1d432f74cd148 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylalanine 20V, Positive-QTOF | splash10-00di-9000000000-a278ac1b63487fce4806 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylalanine 40V, Positive-QTOF | splash10-05fu-9000000000-26d47cd3c8e74226ee49 | 2021-09-23 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB112122 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 5360762 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 6992637 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 75008 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Wallace RJ, McKain N, Broderick GA, Rode LM, Walker ND, Newbold CJ, Kopecny J: Peptidases of the rumen bacterium, Prevotella ruminicola. Anaerobe. 1997 Feb;3(1):35-42. [PubMed:16887560 ]
- Macfarlane S, Macfarlane GT: Formation of a dipeptidyl arylamidase by Bacteroides splanchnicus NCTC 10825 with specificities towards glycylprolyl-x and valylalanine-x substrates. J Med Microbiol. 1997 Jul;46(7):547-55. [PubMed:9236738 ]
- Kawashiro K, Ishizaki H, Sugiyama S, Hayashi H: Esterification of N-benzyloxycarbonyldipeptides in ethanol-water with immobilized papain. Biotechnol Bioeng. 1993 Jul;42(3):309-14. [PubMed:18613014 ]
|
---|